As a new-type foreign trade service provider driven by technology transformation and export business, HiSiaddi has established a "1+2+3+4=1" service system and can supply PEDOT:PSS materials sourced directly from multiple well-known original manufacturers. With over a decade of market experience and technical cooperation with factories, HiSiaddi possesses extensive expertise in product compliance issues. Below is a case handled by HiSiaddi addressing PEDOT:PSS cross-border compliance challenges.
Contact HiSiaddi customer service for more consultation on PEDOT:PSS product compliance issues.
BioElec GmbH, located in the high-tech medical industrial park of Munich, Germany, is a leading European manufacturer of mid-to-high-end flexible medical electrodes. Its core products include single-use ECG monitoring patches, subcutaneous minimally invasive biosensing electrodes and portable blood glucose detection conductive components, classified as Class II medical devices sold to EU hospitals. The company’s annual procurement volume of medical-grade PEDOT:PSS conductive dispersion totals 26 tons, previously sourced exclusively from original Heraeus imported slurry from Germany.
Faced with surging domestic European raw material prices and extended delivery lead times of up to 45 days, the client finalized localized procurement and selected customized low-acid medical-grade PEDOT:PSS from a leading domestic manufacturer. After confirming an initial 8-ton sample order, a chain of six interconnected compliance failures emerged: missing REACH-SVHC notifications, unfiled SCIP declarations, SDS non-compliant with EU CLP regulations, absent medical device-specific RoHS sub-item testing, incomplete ISO10993 medical biocompatibility documentation, and incorrect HS code classification for customs clearance. Finished goods were stranded in domestic warehouses unable to complete export customs declaration.
The German local customs broker explicitly notified the client that any single compliance gap would result in container detention and full return of goods upon arrival at Hamburg Port. Furthermore, the client’s terminal medical devices could not complete EU medical authority filing and mass production, triggering severe risk of breach-of-contract compensation to downstream hospital clients. Domestic raw material manufacturers only specialized in synthetic mass production and could solely issue national standard domestic test reports, lacking expertise in EU REACH, SCIP, CLP and MDR medical device supporting regulations. They were unable to independently complete overseas compliance declarations, bilingual document compilation and third-party specialized testing, so the client urgently entrusted HiSiaddi to oversee full-chain compliance rectification.
Mandatory Compliance Red Lines for the Client: Materials used for EU Class II medical consumables must simultaneously satisfy seven statutory requirements: full REACH regulation control, SCIP substance notifications, stricter medical device limit RoHS 2.0, CLP label specifications, ISO10993-5/-10 biocompatibility testing (cytotoxicity & skin irritation), compliant customs classification, and marine dangerous goods transport identification.
Factory release testing only covered general physical and chemical indicators without screening against the latest ECHA SVHC candidate list of 253 high-concern substances. Initial third-party screening detected trace DBP phthalate additive at 0.13% in the slurry, exceeding the 0.1% notification threshold. With an annual procurement volume of 26 tons (>1 ton), EU regulations mandate SCIP system filing via an EU-based Only Representative (OR); goods without a valid SCIP notification number are prohibited from entering the entire EEA territory. The original manufacturer had no EU-based compliance representative and zero familiarity with SCIP online filing procedures.
The manufacturer provided MSDS compiled per China’s GB/T16483 national standard, a 12-section Chinese-only document missing EU statutory 16 mandatory sections. Critical data including hazard classification, GHS hazard pictograms, toxicological data and EU regulatory clause references were entirely blank. German customs and the client’s laboratory do not recognize Chinese-only SDS. EU regulations mandate bilingual English + German full compliant SDS for exported chemicals aligned with CLP hazard classification rules, a capability absent from the original manufacturer.
The manufacturer’s RoHS test only covered the standard 10 restricted hazardous substances for consumer electronics. EU MDR medical device supporting RoHS imposes far stricter limits on cadmium and four phthalate plasticizers than general electronic products. Hamburg customs clarified that raw materials for medical devices must hold separate third-party RoHS test reports tailored exclusively for medical equipment.
The client’s terminal products contact human skin and subcutaneous tissue, qualifying as Class II medical devices. PEDOT:PSS raw materials require supporting ISO10993 testing covering cytotoxicity, skin sensitization and hemolysis. The manufacturer could only provide industrial-grade raw material quality inspection certificates and had never conducted medical biological toxicology testing; absence of these reports prevents the client’s finished products from medical authority registration and market launch in Germany.
The manufacturer self-declared HS codes under general waterborne paint categories. PEDOT:PSS conductive dispersion contains polar organic solvents and qualifies as low-corrosive general chemical liquid. Misclassified HS codes triggered customs system early warnings. Additionally, no IMDG marine dangerous goods classification identification certificate was issued, leading shipping lines to reject booking requests, leaving goods stranded in warehouses unable to load containers for export.
1. HiSiaddi coordinated with the manufacturing factory’s formulation engineers to replace phthalate additives exceeding SVHC limits with eco-friendly citrate co-solvents. Re-sampling was submitted to SGS for full 253-item SVHC screening post-modification, with DBP concentration reduced to 0.058% (below the 0.1% statutory control threshold), issuing a compliant SVHC test certificate.
2. Leveraging cooperating German local compliance service providers acting as the client’s EU REACH Only Representative, HiSiaddi compiled full product component data, CAS registry numbers, annual export tonnage and production traceability documentation, completed online filing on the official ECHA SCIP system, obtained a unique SCIP notification ID, and archived all filing receipts in the client’s dedicated compliance library to satisfy EU territorial supervision requirements.
Cooperating with domestic compliance laboratories, HiSiaddi compiled full 16-section bilingual English + German SDS fully aligned with REACH and CLP regulations based on authentic product physical, chemical, toxicological and environmental data. Supplementary content included GHS hazard signal words, first-aid response protocols, EU regulatory clauses, waste environmental disposal guidelines and cross-border transport specifications. CLP-compliant outer drum labels were customized and printed on IBC bulk containers, clearly marking product name, manufacturer, EU Only Representative information, GHS hazard pictograms, hazard statements and precautionary statements, fully meeting German import inspection standards.
HiSiaddi selected EU-recognized CNAS-accredited third-party laboratories to re-test samples against stricter medical device RoHS limit values stipulated by EU regulations, enforcing cadmium ≤10 ppm and four phthalates <500 ppm. A dedicated medical-grade RoHS test report was issued within 7 working days, traceable and verifiable by both EU customs and German medical regulatory authorities.
HiSiaddi partnered with domestic laboratories holding medical device toxicology testing qualifications to conduct three core medical tests on finalized mass-production PEDOT:PSS samples: ISO10993-5 cytotoxicity, ISO10993-10 skin irritation and hemolysis assays. Upon passing all tests, bilingual Chinese-English biocompatibility evaluation reports were issued. These reports directly supported the client’s subsequent Class II medical device MDR CE filing, completing raw material market access compliance prerequisites.
Based on PEDOT:PSS component composition and physical/chemical properties, HiSiaddi coordinated with the Shanghai Customs Pre-classification Center to confirm the accurate HS commodity code. The Shanghai Chemical Research Institute was commissioned to issue an IMDG marine cargo safety identification certificate confirming the material as non-high-risk general chemical liquid for marine transport. Customs declaration documents were revised accordingly, passing domestic export commodity inspection and single-window customs pre-review to enable smooth container loading and shipment to Hamburg Port.
1. Smooth customs clearance and mass production launch for initial 8-ton shipment: Full sets of compliance documentation were sent to both the German client and Hamburg customs broker. Goods arrived at port and underwent rapid inspection and release without physical cargo examination upon verification of SCIP ID, bilingual SDS, RoHS and full biocompatibility documentation. The client’s laboratory conducted feeding and pilot trials, confirming raw material performance matching original Heraeus standards, enabling immediate mass production of medical electrodes and on-time delivery of orders to German domestic hospitals.
2. Phased compliance performance for full-year 26-ton orders: The remaining 18 tons were scheduled across 6 monthly production batches. HiSiaddi established a dedicated compliance file library for this product, conducting pre-shipment review of SVHC compliance, label integrity and SDS validity before each batch release, while tracking annual updates to the EU SVHC candidate list to proactively warn of raw material compliance risks driven by regulatory changes. Zero container detention and zero return shipments were recorded for all batches throughout the year.
3. Extended long-term compliance custody service: For the client’s subsequent procurement of modified PEDOT:PSS dedicated to implantable sensors, all full-chain compliance work (annual REACH updates, SCIP modification filings, annual retesting, MDR supporting documentation) was fully entrusted to HiSiaddi for long-term custody. Building on this compliance resolution case, HiSiaddi successively developed three additional European mid-to-high-end medical raw material procurement clients in the Netherlands and Austria.
Domestic PEDOT:PSS manufacturers focus on synthetic production processes and generally lack reserves of multi-jurisdictional EU regulatory expertise, only capable of meeting domestic production quality inspection requirements. They have limited familiarity with cross-border specialized compliance frameworks including REACH, SCIP, CLP, medical ISO10993 and MDR. Mid-to-high-end overseas medical clients face dual stringent supervision from EU medical authorities and customs; any single compliance flaw can lead to full batch cargo loss and blocked finished product market launch. Single-source supply models from manufacturers cannot cover full-chain compliance service demands.
Moving beyond simple raw material trade, HiSiaddi built a closed-loop full-service compliance system covering compliance testing & rectification, EU territorial regulatory filing, bilingual official documentation compilation, customs classification and long-term regulatory dynamic tracking. It bridges the compliance information gap between domestic manufacturers and high-end overseas clients, securing long-term bulk procurement cooperation with mid-to-high-end overseas clients via robust compliance risk control capabilities.
Contact HiSiaddi customer service for more consultation on PEDOT:PSS product compliance issues.
+86-13120989737 
info@hisiaddi.com 
English
